Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT

Clinical trial NCT03114670 · UNKNOWN

Trial details

NCT number: NCT03114670
Sponsor: Affiliated Hospital to Academy of Military Medical Sciences
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Acute Myeloid Leukemia

Start date: 2017-03-25
Primary completion: 2019-03-18
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.